PurTTM
讚了
$滴滴(已退市) (DIDI.US)$
如果這是一個很好的買入,除非他們真的從這股票中賺錢,否則以 14 價購買的機構不能賣掉。對於這家公司的那麼多增長和潛力,現在以 14-15 的價格買入是這樣的折扣。進一步進一步購入現在意味著幾乎買入近 14 間機構買入 🙌🏻
如果這是一個很好的買入,除非他們真的從這股票中賺錢,否則以 14 價購買的機構不能賣掉。對於這家公司的那麼多增長和潛力,現在以 14-15 的價格買入是這樣的折扣。進一步進一步購入現在意味著幾乎買入近 14 間機構買入 🙌🏻
已翻譯
9
2
PurTTM
讚了
$Ocugen (OCGN.US)$ This is why the spike. Moomoo cui, simi not seeing company news
https://www.google.com.sg/amp/s/m.businesstoday.in/lite/story/bharat-biotech-submits-covaxin-phase-iii-clinical-trial-data-to-dcgi/1/442155.html
https://www.google.com.sg/amp/s/m.businesstoday.in/lite/story/bharat-biotech-submits-covaxin-phase-iii-clinical-trial-data-to-dcgi/1/442155.html
10
$Orphazyme (ORPH.US)$
“We are disheartened by the outcome of the FDA’s review, given the urgent need for a new therapeutic option for NPC, but we remain committed to working with the regulators, with the goal of delivering arimoclomol tofamilies managing this challenging disease,” said CEO Christophe Bourdon. He continued: “We will focus our efforts on pursuing the European regulatory approval, with CHMP opinion expected in Q4 2021 and potential Marketing Authorization in Q1 2022. We are assessing the potential path forward in the U.S. in partnership with the FDA. In the short-term, we will need to reduce our costs substantially and freeze all company efforts not related to clinical and regulatory activities to support approval for NPC.”...
“We are disheartened by the outcome of the FDA’s review, given the urgent need for a new therapeutic option for NPC, but we remain committed to working with the regulators, with the goal of delivering arimoclomol tofamilies managing this challenging disease,” said CEO Christophe Bourdon. He continued: “We will focus our efforts on pursuing the European regulatory approval, with CHMP opinion expected in Q4 2021 and potential Marketing Authorization in Q1 2022. We are assessing the potential path forward in the U.S. in partnership with the FDA. In the short-term, we will need to reduce our costs substantially and freeze all company efforts not related to clinical and regulatory activities to support approval for NPC.”...
1
$AMC院線 (AMC.US)$ what time will the show starts tomorrow? 🍿
$Orphazyme (ORPH.US)$ will this be another distraction from AMC?
2